SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-24-000301
Filing Date
2024-03-22
Accepted
2024-03-21 19:34:41
Documents
19
Period of Report
2024-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20240320c_8k.htm   iXBRL 8-K 35071
2 EXHIBIT 5.1 ex_642740.htm EX-5.1 5731
3 EXHIBIT 10.1 ex_642739.htm EX-10.1 216193
8 footer1.jpg GRAPHIC 5161
9 header1.jpg GRAPHIC 5650
10 igc_logo1.jpg GRAPHIC 2673
  Complete submission text file 0001185185-24-000301.txt   472600

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA igc-20240319.xsd EX-101.SCH 3206
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20240319_def.xml EX-101.DEF 10590
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20240319_lab.xml EX-101.LAB 19959
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20240319_pre.xml EX-101.PRE 10950
22 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20240320c_8k_htm.xml XML 2723
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 24772750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)